文献速递乳房整形与再造美容整形

脂肪移植在残余乳腺癌动物模型中的肿瘤学安全性

Oncologic Safety of Fat Grafting for Autologous Breast Reconstruction in an Animal Model of Residual Breast Cancer.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

本研究在小鼠乳腺脂肪垫中建立残余乳腺癌模型,比较肿瘤细胞植入后注射生理盐水(n=20)或人脂肪移植物(n=20)对肿瘤局部复发的影响。结果显示脂肪移植组肿瘤体积和质量更低(p=0.046和p=0.038),Ki67增殖指数更低(p=0.01),组织学分级无显著差异(p=0.17),未见转移病灶。结论支持脂肪移植在乳腺癌术后重建中的肿瘤学安全性。

要点

  • 脂肪移植未增加残余乳腺癌模型的肿瘤大小、增殖、分级或转移。
  • 脂肪移植组肿瘤体积和质量显著低于生理盐水组。
  • 脂肪移植组Ki67增殖指数显著更低,组织学分级无差异。

核心结论

  • 在临床相关动物模型中,残余乳腺肿瘤背景下进行脂肪移植未增加肿瘤大小、增殖、组织学分级或转移。
  • 研究支持脂肪移植作为癌症治疗后乳房重建手术平台的肿瘤学安全性。

研究设计与样本

  • 研究为动物实验,使用雌性NOD-SCID gamma小鼠乳腺脂肪垫注射MCF-7细胞与Matrigel建立残余乳腺癌模型。
  • 肿瘤植入2周后,相邻部位注射生理盐水(n=20)或人脂肪移植物(n=20)。
  • 8周后评估肿瘤体积、组织学分级、Ki67阳性率和转移播散。

主要发现

  • 脂肪移植组肿瘤体积和质量均低于生理盐水组(p=0.046和p=0.038)。
  • 生理盐水组宏观侵犯更高。
  • 两组组织学分级无显著差异(p=0.17)。
  • 脂肪移植组肿瘤周围Ki67增殖指数更低(p=0.01)。
  • 所有动物均未发现转移病灶。

临床怎么用

  • 该动物模型结果支持脂肪移植在乳腺癌术后重建中的肿瘤学安全性,但需结合临床证据综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical outcomes suggest that postoncologic reconstruction with fat grafting yields cumulative incidence curves of recurrence comparable to those of other breast reconstruction procedures; however, results from experimental research studies suggest that adipose stem cells can stimulate cancer growth. In this study, a novel animal model of residual cancer was developed in mouse mammary pads to test whether lipofilling impacts the probability of locoregional recurrence of breast cancer after breast conserving surgery. METHODS: Mammary fat pads of female NOD-SCID gamma mice were each injected with MCF-7 cells in Matrigel. Tumors were allowed to engraft for 2 weeks, after which time either sterile saline (n = 20) or human fat graft (n = 20) was injected adjacent to tumor sites. After 8 weeks, tumors were assessed for volume measurement, histologic grade, Ki67 positivity, and metastatic spread. RESULTS: Animals receiving lipofilling after tumor cell engraftment had lower tumor volume and mass (p = 0.046 and p = 0.038, respectively). Macroscopic invasion was higher in the saline group. Histologic grade was not significantly different in the two groups (p = 0.17). Ki67 proliferation index was lower in tumors surrounded by fat graft (p = 0.01). No metastatic lesion was identified in any animal. CONCLUSIONS: Adipose transfer for breast reconstruction performed in the setting of residual breast tumor in a clinically relevant animal model did not increase tumor size, proliferation, histologic grade, or metastatic spread. This study supports the oncologic safety of lipofilling as part of the surgical platform for breast reconstruction after cancer therapy.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Silva MMA, Kokai LE, Donnenberg VS, et al. Oncologic Safety of Fat Grafting for Autologous Breast Reconstruction in an Animal Model of Residual Breast Cancer. Plast Reconstr Surg. 2019. PMID: 30589782. doi:10.1097/PRS.0000000000005085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。